Zhiwu Wang
Tangshan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Plain language summary: comparing ivonescimab plus chemotherapy with tislelizumab plus chemotherapy in people with advanced squamous non-small cell lung cancer in the HARMONi-6 study.
Journal: Future oncology (London, England)
Published: June 03, 2026
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy in advanced squamous non-small-cell lung cancer (HARMONi-6): interim overall survival analysis of a randomised, double-blind, phase 3 trial in China.
Journal: Lancet (London, England)
Published: April 23, 2026
SAMHD1 drives immunosuppression in non-small cell lung cancer by promoting macrophage infiltration and restricting oncolytic adenovirus replication.
Journal: Journal for immunotherapy of cancer
Published: January 08, 2026
Value of PD-1 and CD28 expression on T lymphocytes in predicting radiation-induced lung injury: a prospective observational study.
Journal: Neoplasma
Published: December 08, 2025
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial.
Journal: Lancet (London, England)
Published: July 23, 2025
The LBX2-AS1-miR-491-5p-PKM2 Positive Feedback Loop Promotes Radiation Resistance of Esophageal Cancer by Enhancing Glycolysis.
Journal: BioMed research international
Published: July 03, 2025
Prediction of microsatellite instability in colorectal cancer based on tissue phenotypes inferred from pathological whole slide images using self-distillation.
Journal: Pathology, research and practice
Published: July 02, 2025
Pharmacological Vitamin C Plus Oncolytic Adenoviruses Orchestrate Immunogenic Tumor Ferroptosis.
Journal: Journal of medical virology
Published: June 25, 2025
Knockdown of MACC1 expression attenuates colorectal cancer cell glucose metabolism by suppressing GLUT4 membrane translocation.
Journal: Cancer biomarkers : section A of Disease markers
Published: June 12, 2025
Tumor microenvironment signatures enhances lung adenocarcinoma prognosis prediction: Implication of intratumoral microbiota.
Journal: Microbial cell (Graz, Austria)
Published: May 14, 2025
Hyaluronic acid-modified milk exosomes carrying ZNF516 inhibit ABCC5 and contribute to pemetrexed sensitivity in lung adenocarcinoma.
Journal: Human cell
Published: January 09, 2025
Efficacy and safety of IBI351 (fulzerasib) monotherapy in KRASG12C inhibitor-naïve Chinese patients with KRASG12C-mutated metastatic colorectal cancer: a pooled analysis from phase I part of two studies.
Journal: Signal transduction and targeted therapy
Published: November 14, 2024
Last Updated: 09/26/2026